180 related articles for article (PubMed ID: 38074914)
1. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma.
Zhang YB; Yang G; Bu Y; Lei P; Zhang W; Zhang DY
World J Gastroenterol; 2023 Nov; 29(43):5804-5817. PubMed ID: 38074914
[TBL] [Abstract][Full Text] [Related]
2. Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma.
Dong B; Zhang H; Duan Y; Yao S; Chen Y; Zhang C
J Transl Med; 2024 May; 22(1):455. PubMed ID: 38741163
[TBL] [Abstract][Full Text] [Related]
3. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
[TBL] [Abstract][Full Text] [Related]
4. Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy.
Yan M; Zhang X; Zhang B; Geng Z; Xie C; Yang W; Zhang S; Qi Z; Lin T; Ke Q; Li X; Wang S; Quan X
Eur Radiol; 2023 Jul; 33(7):4949-4961. PubMed ID: 36786905
[TBL] [Abstract][Full Text] [Related]
5. Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study.
Liu R; Wu S; Yu HY; Zeng K; Liang Z; Li S; Hu Y; Yang Y; Ye L
Heliyon; 2023 Nov; 9(11):e22458. PubMed ID: 38034691
[TBL] [Abstract][Full Text] [Related]
6. [Application value of machine learning algorithms for predicting recurrence after resection of early-stage hepatocellular carcinoma].
Ji GW; Wang K; Xia YX; Li XC; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):679-685. PubMed ID: 34192861
[No Abstract] [Full Text] [Related]
7. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
Zhang Y; He D; Liu J; Wei YG; Shi LL
World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
[TBL] [Abstract][Full Text] [Related]
8. Deep Learning Model for Predicting Proliferative Hepatocellular Carcinoma Using Dynamic Contrast-Enhanced MRI: Implications for Early Recurrence Prediction Following Radical Resection.
Qu H; Zhang S; Guo M; Miao Y; Han Y; Ju R; Cui X; Li Y
Acad Radiol; 2024 May; ():. PubMed ID: 38749868
[TBL] [Abstract][Full Text] [Related]
9. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular Carcinoma.
He Y; Luo L; Shan R; Qian J; Cui L; Wu Z; Tu S; Zhang W; Lin W; Tang H; Huang Z; Li Z; Mao S; Li H; Hu Z; Liu L; Shen W; He K; Li Y
J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237069. PubMed ID: 38118280
[TBL] [Abstract][Full Text] [Related]
11. Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.
Ma Y; Gong Y; Qiu Q; Ma C; Yu S
BMC Cancer; 2024 Mar; 24(1):363. PubMed ID: 38515051
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.
Cha DI; Jang KM; Kim SH; Kim YK; Kim H; Ahn SH
Korean J Radiol; 2020 Apr; 21(4):402-412. PubMed ID: 32193888
[TBL] [Abstract][Full Text] [Related]
13. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
14. Predicting tumor recurrence on baseline MR imaging in patients with early-stage hepatocellular carcinoma using deep machine learning.
Kucukkaya AS; Zeevi T; Chai NX; Raju R; Haider SP; Elbanan M; Petukhova-Greenstein A; Lin M; Onofrey J; Nowak M; Cooper K; Thomas E; Santana J; Gebauer B; Mulligan D; Staib L; Batra R; Chapiro J
Sci Rep; 2023 May; 13(1):7579. PubMed ID: 37165035
[TBL] [Abstract][Full Text] [Related]
15. Predicting One-year Recurrence of HCC based on Gadoxetic Acid-enhanced MRI by Machine Learning Models.
Lin Y; Wang J; Chen Y; Zhou X; Tang M; Chen M; Song C; Xu D; Peng Z; Feng ST; Zhou C; Dong Z
Curr Med Imaging; 2024 Mar; ():. PubMed ID: 38462826
[TBL] [Abstract][Full Text] [Related]
16. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
17. Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning.
Saito A; Toyoda H; Kobayashi M; Koiwa Y; Fujii H; Fujita K; Maeda A; Kaneoka Y; Hazama S; Nagano H; Mirza AH; Graf HP; Cosatto E; Murakami Y; Kuroda M
Mod Pathol; 2021 Feb; 34(2):417-425. PubMed ID: 32948835
[TBL] [Abstract][Full Text] [Related]
18. Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection.
Zeng J; Zeng J; Lin K; Lin H; Wu Q; Guo P; Zhou W; Liu J
Hepatobiliary Surg Nutr; 2022 Apr; 11(2):176-187. PubMed ID: 35464276
[TBL] [Abstract][Full Text] [Related]
19. A Promising Preoperative Prediction Model for Microvascular Invasion in Hepatocellular Carcinoma Based on an Extreme Gradient Boosting Algorithm.
Liu W; Zhang L; Xin Z; Zhang H; You L; Bai L; Zhou J; Ying B
Front Oncol; 2022; 12():852736. PubMed ID: 35311094
[TBL] [Abstract][Full Text] [Related]
20. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
